Exhibit 10.19
	
	

2019	Di)a)C)ar
t)a,	I
nc.	All

rights	reserved.



e













DIACARTA


CLINICAL

TESTING

&

DISTRIBUTION

AGREEMENT


Nonagen Bioscience Corporation












Date	Prepared


DiaCarta,	Inc.


Nonagen	Bioscience	Corporation


A
pril	26
,	202
2



4385	Hopy)ard	Rd,	Ste	100


Ple)as)a
nto
n,	)CA	94588



United	St)ates


P:	+1	510
-
878
-
6662


F:	+	1	510
-
735
-
8636


E:	inform)ation@di)ac)art)a.com


3680	Wilshire	Blvd

Ste	P04
-
1399

Los	Angeles,	)CA	90010

United	St)ates


P:


E:
info@non)agen.com







	
	Di)a)C
)art)a
)Clinic)al	Testing

Agree
ment
–

Non)agen



P
)age
2

of	11


THIS	AGREEMENT	IS	MA
DE	THIS
DAY

A
PRIL

27,
202
2

BY	AND	BETWEEN
NONAGEN	BIOSCIENCE	C
ORPORATION

WITH	ITS	PRIN)CIPAL	P
LA)CE	OF	BUSINESS
LO)CATED	AT
3680	WILSHIRE	BLVD	S
TE	P04
-
1399,	LOS	ANGELES,	)C
A
9001
0
,	USA	(THE	")COMPANY"
))	AND
DIACARTA,	INC.
WITH	ITS	PRIN)CIPAL	P
LA)C
E	OF	BUSINESS	LO)CATE
D

4385
H
OPYAR
D	RD,	STE	100,	PLEAS
ANTON,	)CA	94588,	USA

(THE	"
)CLINI)CAL	LABORATORY
"))Cla.



Definitions
..		For	purposes	of	this	Agreement,	the	terms	below	sh)al
l	h)ave	the	me)anings	set	forth	below.


Services
:

me)ans	)any	l)abor)atory	testing	services

or	p)art	thereof	sol
d

or	per
forme
d	by
)Clinic)al	L)abor)atory	using	)a


Product
Kit

for	one	of	the	3	indic)ations:	bl)adder	c)ancer	surveill)ance,	ev)alu)ating	hem)aturi)a	)and	predicting
response	to	B)CG
..



Product	Kit
:
me)ans	the

)Comp)any
’
s

b
l)adder	c)ancer	di)agnostic
k
it,
Oncuri)a
®
..



E
xclusi
ve	Per
iod
:	me)ans	the	period	beginning	on	the	Effe
ctive	D)ate	)and	ending	upon	FDA	)approv)al	or	cle)ar)ance
for	one	of	the	3	indic)ations	noted	)above	unless	termin)ated	sooner	pursu)ant	to
P)art
9

(
B))
..


Field
:

me)ans	the	field	of	bl)adder	c
)a
ncer	identific)ation,

screen
ing,	s
t)aging,	predisposition,	di)agnosis,	prognosis,
monitoring,
prevention,

or	tre)atment	selection	thereof	in	hum)ans

for	clinic)al	decision	m)aking.


Prim)ary

Territory
:
In	North	Americ
)a,	including	United	St)ates	)and	)C)an)a
d
)a.



Supplier
:	me
)ans	the	)Co
m
p)any
’
s	desig
n)ated	supplier	of	the	Product	Kit.


NOW,	THEREFORE,	IN	)C
ONSIDERATION	OF	THE
PROMISES	HEREINAFTER

MADE	BY	THE	PARTIES
HERETO,	IT	IS
AGREED	AS	FOLLOWS:



PART	1.	APPOINTMENT
OF
CLINICAL
TESTING	RIGHTS



a.

Te
s
ting

Right
s
..

)Comp)any	hereby	gr)a
n
ts	to

)Clinic
)al	L)abor)atory
the	)ability	to
use	the
product	kit
to	test,
perform,	m)arket,	offer	for	s)ale,	sell	)and	otherwise	commerci)alize	Services	solely	within	the	Field	during	the
Term	)as	)a	l)abor)atory	developed	test	(LDT))Cha.

T
he
services
gr)anted	under

this
s
ectio
n

sh)all

be	exclusive

)and
non
-
tr)ansfer)able

t
o	)C
linic)al	L)abor)atory

in	the	Field	in	the	Prim)ary	Territory	during	the	Exclusive	Period,	)and
)autom)atic)ally	becomes	non
-
exclusive	there)after.	Non)agen	reserves	the	right	to	gr)an
t

Dr.	)Ch)arles	Rosser	the
right	t
o

use
the
P
ro
duct
K
it
f
or	the	purposes	of	c
onducting
c
linic)al
t
ri)als.	Furthermore,	Non)agen	reserves	the
right	to	gr)ant
other
rese)archers,	)at	its	sole	discretion,	the	right	to	use	the
P
roduct
K
it

solely	for	the	purposes
of	)ac
)a
demic	rese)arch.


b.

Obligation.

T
h
e
)Cli
nic)al	L
)abor)atory

will	t)arget
customers	who	)are	clinici)ans	or	clinici)an	groups	who	ev)alu)ate
)and/or	m)an)age	bl)adder	c)ancer	p)atients
)and	di)agnostics	l)abor)atories
..
Licensed
S
ervices

will	be	uplo)aded	in
the

)Clinic)al	L)abor)ato
r
y	di)agnostic	test	menu

for	thei
r

cust
o
mers	t
o	e
nsure	)accessibility	for

the
p)atients,
tre)ating	physici)an
s

)and	di)agnostics	l)abor)ator
ies
..	The
)Clinic)al	L)abor)atory

will	)also	t)arget	clinici)ans	working	on
Person)alized	Medicine	)and	other	st)akeholders	such	)as	poli
c
y	m)akers.




)Clinic)al	L
)a
bor)at
ory

)a
gr
ees	to	use	commerci)ally	re)ason)able	efforts	to	commerci)alize	Services.


c.

Pr
oduct
..

)Comp)any	h)as	)adopted	)a	sep)ar)ate	onbo)arding	process	to	)authorize	)Clinic)al	L)abor)atory	to	pl)ace
Purch)ase	Orders	with	the	)Comp)any’s	Supp
l
ier	for	the	product.	Supplier	i
s

then

)auth
or
ized	to	sell	Product	to
)Clinic)al	L)abor)atory	under	Supplier’s	sep)ar)ate	purch)ase	)a
greement	with	)Clinic)al	L)abor)atory.









	
	Di)a)C
)art)a
)Clinic)al	Testing

Agree
ment
–

Non)agen



P
)age
3

of	11


d.

Competitive	Products.

)Clinic)al	l)abor)atory
m)ay
not	offer	other
hum)an	bl)adder	c)ancer	di)agno
s
tics

tests	)as
l)abor)atory	developed	te
sts
(
LDTs
))

or
in	vitro	di)agnost
ics	(
IVDs
))
..


P
A
RT	2.	PRIC
IN
G	AND	PURCHASING


For	purposes	of	this	Agreement,	“Net	S)ales”	me)ans	the	revenue	gener)ated	by	)Clinic)al	L)abor)atory	from	the	s)ale
of	the	Product	Kits	but	excludes

)any:	(i))

discounts	)allowed	in	)amounts

custom)ary	in
t
he	tr)ade;	(ii))

s)ales	t)ariffs,
d
u
ties	)and/o
r
t)axes	imposed	on	s
uch	Product;	(iii))

outbound	tr)ansport)ation	prep)aid	or	)allowed;	)and	(iv))

)amounts
)allowed	or	credited	on	returns.		For	the	)avoid)ance	of	doubt,
no	deduction	from	Net	S)ales	sh)all	be	m
)ade	for
commis
s
ions	p)aid	to	individu)als	(wheth
e
r	independ
en
t	s)ales	)agents	or
persons	regul)arly	employed	by	)Comp)any
or	)Clinic)al	L)abor)atory))Cha.



The	pricing	)and	purch)asing	of	the
P
roduct
K
its	to	the	)Clinic)al	L)abor)ator
y	will	be	set	forth	in	the	)Clinic)al
L)a
bor)atory’s	sup
p
ly	)agreement	with	the	)Comp)any’s

S
upplier.




)Clinic)al	L)abor)atory
will	ret)ain
sixty

six

percent	(
6
6
%))Cva	of	the
net	s)ales,	while	)Comp)any	will	be	p)aid
thirty	three

percent	(
33
%))Cva	of	the	net	s)ales.	)Clinic)al

L)abor)atory

will	remit	to
)Comp)any

th
is

rem)aining	per
c
ent)age	within	thirty
(30))	d)ays
o
f	its	rece
ip
t	of	the	rel)ated	p)ayments	from	the	third	p)arty.



)Comp)any	sh)all	h)ave	the	right,	upon	re)ason)able	notice	to	)Clinic)al	L)abor)atory,	to	)audit	the	books	)and	recor
ds	of
)Clinic)al	L)abor)atory

in	order	to
determine	the
)a
ccur)acy	of	the	Product	Percent)a
g
e	P)ayments

m
)ade	pursu)ant	to
this	Secti
on.

The	costs	of	such	)audit	sh)all	be	p)aid	by	)Comp)any	unless	the	)audit	discovers	)an	underp)ayment	of
five	percent	(5%))	or	more,	in	whic
h	event	the	costs	of	s
uch	)audit	sh)all
be	p)aid	by	)Cli
n
ic)al	L)abor)atory.		)Comp)any
m)ay	e
x
ercise	suc
h
)audit	right	no	more	th)an	once	per	ye)ar.


Late	Payment
..

Any	sum	of	money	due	to	)Comp)any	under	this	Agreement	which	is	not	duly	p)aid	on	time	sh)all
be)ar	interest
from	t
he	due	d)ate	of	p)ayment	until	the

)actu)al	d)ate	o
f

p)ayment	)at	the	r)ate	of	one	)and

)a	h)alf
per
ce
nt	(1.5%))Cha	per	month	)accumul)ated	on	)an	)annu)al	b)asis.


PART	3.
DILIGENCE



Specific	Diligence	Milestones
..
)Clinic)al	L)abor)atory
)agrees	to	use	commerci)ally	re)ason)ab
le	efforts	to	meet	)all	of
the	followin
g	due	diligenc
e

requirements
:


•

A
chieve	the	)Com
m
erci)al	L)au
nc
h	D
)ate
within
t
wo	months
(2))
following

the	su
ccessful	v)alid)ation	of	the
product	in	the	)Clinic)al
L)ab
or)atory
:


•

P
erform	)and	sell	)at	le)ast
Two
Thous)and

F
iv
e
H
un
dred

(2,
5
0
0
))
tests

th)at	)are	Serv
ices	wit
hin	the	first	ye)ar
of	the	)Commerci)al	L)aunch
D
)ate
(cumul)ative
,	o
ver	such
o
ne
(
1
))	ye)ar	period))
;


•

P
erform	)and

s
ell	)at
le)ast

S
even

Thous)and

Five
Hundred

(
7
,
5
00))Cga
tests	th)at	)are	Services	within	two	(2))
ye)ars	of	the	)Co
mmerci)al	L)aunch	D)ate

(cumul)ative,	over	such	t
wo	(2))Cva	ye)ar	period))Cva;

•

P
erfo
r
m	)and	sell	)at	le)ast
F
ifteen
Thous)and
(1
5
,
000))Cga
tests	th)at	)are	Services	within	three	(3))

ye
)a
rs	of	the
)Co
m
merci)al	L)aunch	D)ate	(cumul)ative,
o
v
e
r

s
uch	three	(3))Cha	ye)ar	period))Cha	)and

•

M
)a
int)ain

Twenty

Thous)and	(
20
,00
0
))

tes
t
s
s)ales
)annu)ally

going	forw)ard
..


In	the	event	)C
linic)al	L)a
bor)ator
y	f)ails	to	meet	its	oblig)ations	described	)above	)an
d	if	ope
n	rece
i
pt	of	writte
n	not
ice
of	such	f)ailure

is	not	cured	by	)Clinic)al	L)abor)atory	w
ithin	one	hundred	)and	tw
enty	d)ays	(120))Cga	d)ays,	then	)a
s

)Comp)any’s	sole
)and	exclusive	remedy,	)Comp)any	s
h)all	h)ave
the	rig
ht	to	termin)ate	the	Agreement	upon	written
notice

to	)Clin
ic)al	L)a
b
or)atory.









	
	Di)a)C
)art)a
)Clinic)al	Testing

Agree
ment
–

Non)agen



P
)age
4

of	11




PART
4
..	MARKETING	AND
SALES
SUPPORT


A.

Sales.

)Clinic)al	L)abor
)atory
sh)all	use	its	best

efforts	to	promote	the	s)ale

)and	distribution

of	the	Product

Kit

)and
to	prov
ide	)adequ)a
te	supp
ort,	which	efforts	sh)all	include	the	following:


i.

Provide
)an	)adeq
u
)ate,	tr)ained

s)al
es	)and	technic)al	st)aff	to	promote	the	s)a
le	)and	support	of
the
Product

Kit
;

ii.

Undert
)ake	promotion)al	c)amp)aigns	)an
d

c)anv)as	prospect
ive	users	to	stimul)ate	the	s)ale
s	of	Produ
ct

Kit
;


iii.

Provide	)Comp)any	with	forec)asts	every	qu)arter	of	its	pro
b)abilit
y

requirement
s	fo
r	the	next	six
months	for	Product,	such	fore
c)asts	to	be	in

such	m)anner	)and	on	form
s	to	be	specified	by	)Comp)any

)and	)agreed	to	by

)Clinic)al	L)abor)atory
;


iv.

Furtherm
ore,	)all
)C
linic)al

L)abor)atory

employees	in	direct	cont)act	with	custome
rs	must	h)ave

)a
biomedic)a
l

b)ackground	)and	experience.


B.

Advertising.

)Comp)any
)and	its	)af
fili)ates
sh)all

)assist	the

)Clinic)al	L)abor)atory

on	)all

)a
dvertising,	s)ale
s	promotion,
)and	publi
c	rel)atio
ns	c)amp)aig
ns	to	b
e	conducted	)and	sh)all	provide	necess)ary	technic)al	in
form)ation	)an
d

)assist)ance
..



C.

Training.
)Comp)any
)and	its	)affili)ates
sh)all	furnish	tr)ainin
g	of
)Clinic)al	L)abor)atory'
s
s)ales	)and	technic)al
repre
se
nt)atives	)at	v)ari
ous	times	mutu)ally	)agreed	to	by

the	P)arti
es	)and
)Comp)any	sh)all	design)ate	loc)ations	)as
for	this	purpos
e.	Enrollmen
t

in	tr)ainin
g

courses	sh)all	be	limited	to	)a	re)ason)able	number	of	persons	w
ho	sh)all
be	sufficiently
qu
)alified	to	t)ake	the	cours
es
..	Tr)aining
m)ay
b
e	provided	using	on
-
line	tools
,

w
ebin)ars

or	in
-
p
erson	modules
..



D.

Regional	Technical	Support.

Th
e
)Clinic)al	L
)a
bor)atory
wi
l
l	)assign	one	design)ated	employee	to	)act	)as	technic)al
support
for	the	)Comp)any
’
s

P
roduct

Kit
..	The	)Comp)any	will	prov
id
e	regul)ar	worksh
ops	)and	)adv)anced	tr)aining
on	)al
l	Product

Kits
..





PART
5
..	DELIVERY


A.

Product.

)Comp)any	h)as	)ado
pted	)a	sep)ar
)a
te	onbo)ardi
n
g	process	to	)authorize
)Clinic)al	L)abor)atory

to	pl)ace
Purch)ase
Orders	with	the	)Comp)any’s

Supplier	for	the	product.
Su
pplier	is	then	)a
uthorized	to	sell	Product	to
)Cl
inic)al	L)ab
or)atory

under	Supplier’s	sep)ar)ate	purch)ase	)agreement	with
)C
linic)al	L)abo
r
)atory
..


B.

Pu
r
chase	Orders.

)Clinic)al	L)abor)atory
sh)all	order	Product
Kits
by

written	notice	to	)C
omp)an
y’s	Supplier
..	E)ach
order	sh
)al
l	specify	the	nu
mber	of	units	to	be	shipped,	th
e	type	of
units	t
o	be	shipped	()as	identified	by

Supplier’s
c)at)al
ogue	number
d
esign
)ations

indic)ated	in	the	Price	List))CIAa	including	)all	option)al	fe)atures,

)and	the
desired	method	o
f	shipment.



C.

Shipment
..

All	shipments	of

Product	Kits
sh)all	be	m)ade	by
Supplier
d
esign)at
ed	by	)Comp)any	to	ship	product
..

)Comp)any	sh)all	no
t	be	in	def)a
u
lt	by	re)aso
n

of	)any	f)ailure
of	Supplier	to	provide	the	Product	Kits
,	n
or
sh)all	the
)Comp)any	)at	)any
time	be	li)able	for

)any	inci
de
nt)al,	speci)al	or

consequenti)al	d)am)ages.


PART
6
..	PROPRIE
TARY	RI
GHTS








	
	Di)a)C
)art)a
)Clinic)al	Testing

Agree
ment
–

Non)agen



P
)age
5

of	11


A.

Use	of	Company	Name.

)Comp)any	expressly	proh
ibits	)any	direc
t

or	indirec
t

use,	reference	to,	or	other
employment	of	its	n)ame,	tr)adem)ar
ks,	or	tr)ade	n)ame	exclusi
vely	licensed	to	)Comp)any,	e
xc
ept	)as	specified

in
this	Agreement	or	)as	expres
sly	)author
ized	by

)Comp)any	in	writing.	All	)a
dvertising	)and	other	pr
omotion)al
m)ater
i
)al	will	be
s
ubmitted	to	)Comp)any	)at	le)ast
14

working	d)ays	in	)adv)ance	)and	w
ill	only	be	used	if	)Comp)a
ny
consents	thereto,	which
co
nsent	sh)all	not
be	unre)ason)ably	withheld.	Furth
ermore,	Th
e	)Comp)a
ny	will	use
best	comm
erci)al	efforts	to	respond	wi
thin	3	working
d
)ays	from	th
e

initi)al	d)ate	of	submission.	)Comp)any
hereby	)authorizes	)and	re
quires
)Clinic)al	L)abor)ator
y's
use	of	the	)Comp)any's	in
si
gni)a	or	letterin
g	which	will	be
on	the	products

)at	the	ti
me	of	t
he
delivery.	)Comp)any	hereby	)authorizes	the
)Clinic
)al	L)abor)atory's

use	of	the
l
ogo	set	forth	below.	The
)Clinic)al	L)abor)atory
sh)all	submit	to
the

)Comp)any
in	writing	fu
ll	p)articul)ars	prior	to
)any

u
se	of	the

)Comp)an
y’s
logo,	on	st)ationery,	invoic
es,	promot
ion	m)at
eri)al	or	otherwise,	)and	sh)all	not
proceed	with	su
ch	use	unless	)a
n
d	until	the

)Comp)any's	written	)approv)al	sh)all	h)ave	been	received.


i.


)Co
mp)any’s
logo	sh)all	be	the

following:


ii.

If	the	)autho
ri
zed	logo	is	used

on	)any	st)ationery,	invoices,	p
romotion	m
)ateri)al

or	otherwise	by

)Clinic)al	L)abor)atory
,
)Clinic
)al	L)abor)atory
w
i
ll,	on	term
i
n)ation	of	this	Agreement,	or	upon	request	of
)Comp)any,	discont
inue	the	use	of	such	logo

on	)any	st)ationery,	invoice
s,

promotion	m)ater
i)al	or
otherwise	)and	there)after

will	not
use,	ei
ther	directly	or	indirectly	in	connection	with	it
s	business,
su
c
h

logo	or	)an
y

other	n)ames,	titles	of	expressions	so	ne)arly	resembling	the
s)ame	)as	would	likely
le)ad

to	confusion	or	uncert)aint
y,

or	to	deceive	t
he	public.


B.

Patent	Indemnity.

)C
omp)any	)agr
ees,	)at

its	own	expense,	to	indemnify,	defend	)and	hold	h
)armless

)Clinic)a
l

L)abor)atory

)and	its	customers	from	)and	)ag)ainst	every	expense,	d)am)age,	cos
t	)and	loss	(including	)att
orneys'
fees	incurred))	)and
to

s)atisfy	)all	jud
gments	)and	decrees	resulting	fr
om	)a	cl)aim
,	suit
or	proceeding	insof)ar	)as	it
is	b)ased	upon	)a
n	)alle
g)ation	th)at	the

Product
Kit

or	)any	p)art	thereof	furnished	by	)Comp)any	or	)any	process
which

is	pr)acticed	in	the	cust
om)ary	use	of	the	Product
Ki
t
is	or	h)as	been	i
nfringing	upon	)any	p)atent,
copy
right	or	p
ropriet
)ary	right,	if	)Comp)any	is	notified	promp
tly	of	suc
h	cl)aim	in	writ
i
ng	)and	give
n

)authority,
)and	full	)and	proper	inform)ation	)and	)assist)ance	()a
t	)Comp)any's	expense))	for
the	defense	of	s)ame.	In	c)as
e
the
Product

Kit
,

or	)any	p)art	thereof,	in	such	s
uit	is	hel
d	to	co
nstitute	)an	infringement	)and	the	use
of	s)aid	Prod
uct
Kit
or	p)art

is	enjoined
,

)Comp)any	sh)all,	in	its	sole	discretion	)and	)at	its	own	expense
,	either	procure	for	the
indemnitee	the	right	to	con
ti
nue	using	s)aid	P
roduct
Kit
or	p)art	or	repl)ace	o
r	modify	t
he	s)ame

with
nonperform)ance	or	c)ap)acity
or	)affect	its	co
mp)atibility	wit
h

the	h)ardw)a
r
e	or	firmw)are	comprising	the
Product
Kit
or	the	softw)are	util
ized	thereon.


C.

Drawings
and	Data.

The	)Comp)any	suppl
ie
s	)all	necess)ary
d)at)a	for	the	proper
test,	oper)a
tion,	use

)and
rep
orting
of	its

Product	Kit
..
Portions	of	this	d)at)a
)are	propriet)ary

in	n)ature	)a
n
d	will	be	so	m)arked.	The

)Clinic)al	L)abor)atory
)agrees	to	)a
bide	by	the	terms	of	such

m)arkings	)and	to	be	li)ab
le
fo
r	)all	loss	or	d)a
m)age
incurred	by	the	)Comp)any	)as

)a	result
of	the
improper	or	un)authorized	use	of	such	d)at)a.	The	)Co
mp)any	ret)ains
f
o
r	itself	)al
l

propriet)ary	rights	in	)and	to	)all	designs,	clinic)al	d)at)a,	eng
ineering	det)ails,	)and	oth
er	d)at)a
pert)aining	to	)an
y

P
ro
duct	Kit
specifi
ed	in	the	contr)act	)and	to	)all	d
iscoveries

invent
ions,	p)atent	rights,	etc.,






	
	Di)a)C
)art)a
)Clinic)al	Testing

Agree
ment
–

Non)agen



P
)age
6

of	11


)arising	out	of	w
ork	done	in	connectio
n

with
the	co
ntr)act	)and	to	)any	)and	)all
Product	Kits
developed	)as	)a
result
thereof,	including	th
e	so
le	right	to	m)anuf)acture	)any

)a
nd	)all	such	prod
ucts.



P
ART
7
..	CONFIDENTIALIT
Y


A.

During	the	Ter
m	of	this

Agreement

)and	for	)a	period	of	two

(2))	ye)ar

the
re)after,	e)ach	P)arty	(“Receiving
P)arty”))Cga	sh)all	tre)at	)all	d)at)a,	inform)ation	)and

m)ate
ri)als

disclosed	or	provid
ed	by	the	other	P)arty	(“Disclosing
P)arty”))Cga	in

perform)ance	of	the

Services	)and	the	M)ateri)als

(
“)Confidenti)al	Inform)ation”))Cla	)as	confidenti)al	)and
propriet
)ary	of	the	Disclosing	P)arty	)and	sh)all	not	permit	such	)Confidenti)al	Inform)ation	to
be	disclosed	to	or
used	b
y	)any	third

p)arty

)and	sh)all	not	use	)Confident
i)al	Inform)ation	for	)any	purposes	other	th)an	for
the
perform)ance	of	the	Services	or	other	)activities	cons
istent	with	this

Agreement.


Both
)Cl
inic)al	L)abor)atory

)and	)C
omp)any

m)ay	receive	)and
sh)al
l	keep	confidenti)al	)a
n
y	info
rm)atio
n	tr)ansmitted
in	confidence	from

one	P)arty	(the	“Disclosing	P)arty”))Cha	to	the	other

P)arty	(the	“Receiving	P)arty”))Cga.	T
he

oblig)ations	of	the	Receiving	P)arty	reg)arding	c
onfidenti)a
lity	for	)any	info
rm)ation	disclosed	hereunder	s
h)all

not
include:


i.

Infor
m
)ation
which
is	or	becomes	publicly	known	thr
ough	no	wrongful	)act	of	the	Receiving	P)arty;

ii.

In
form)ation	which	w)as	known	to	the
Re
ceiving	P)arty	prior	to	signing	this	document	)as

evidenced

by
its	written	records;	)and

iii.

Inform)ation	which

is
received	by	the	Recei
v
ing	P)a
rty	fr
om	)a	third	p)arty	without	restric
tion	of
confidenti)ality;	)and

iv.

Inform)ation	th)at
is

independently	developed	by	or	on

b
eh)alf	of	the	Receiving	P)arty	without	reli)ance
o
n	the	)Conf
identi)al	Inform)ation	received	hereunder,	)as	re
)ason
)ably	evidenced	by	its

writte
n	reco
rds.


B.

A	Receiving	P)arty	sh)all	d
isclose	the	)Confidenti)al	Inform)ation	only
to	its

employees	who	must	h)ave	)access	t
o
the	)Confidenti)al	Inform)ation	in	order	to	perfor
m	services

under	this	Agreement.


C.

A	Receiving	P)arty	sh)a
ll	n
ot	use	)any	)Confidenti
)a
l	Info
rm)atio
n	except	for	the	perform)ance	of
the
Services
..


D.

If	disclosures	of	)Confidenti)al	In
form)ation	)are	requested	by

)any	gover
nment)al	)agency,	the	Receiving	P)arty
sh)all	promp
tly	notify

the	Disclosing	P)arty	of	such	request.



E.

If	)Comp)an
y	instructs
)Clinic)al

L
)abor)atory

no
t
to	comply	with	such	request	f
or	disclosure	)and	i
ndemnifies
)Clinic)al	L)abor)ator
y

)ag)ainst	loss,	cost,	or	e
xpense	)ari
sing	from	deni)al	of	the	request,
)Clinic)al	L)abor
)atory

sh)al
l
not	rele)ase	)any

such	)Confidenti)al	In
form)ation	except	where	such	disc
l
o
sure	is	comp
elled	by	court	ord
er	or
)applic)a
ble	l)aw.	In	the	event	such	disclosu
re	is	require
d	by	)a	v)alid	order	of	)a	co
urt	or	oth
er	government)al
body	h)aving	jurisdiction	or	by
)applic)able

l)aw,
)Clinic)al	L)a
bor)atory

m)ay	disclose

)Confidenti)al	Inform)ation,
witho
u
t

viol)ating	i
ts	oblig)ations	under	this
Agree
ment,	provided	th)at
)Clinic)al	L)abor)atory

gives	re
)aso
n)able
prior	written	not
ice	to	)Com
p)any	of	such	required	disclosure.


PART
8
..	WAR
RANTY


A.

Kit

Warranty.

)Comp)any	w)arr)ants	th)at	the
P
roduct
K
its	)are	free	from	defect

)a
nd	)are	fit	f
or
its	specific
purpose	unless
the	shipping	con
t)ainer	h)as	been	d)am)aged	in	tr)ans
it.	D)am)age	constitutes	the

shipping
cont)ainer	h)as

been	opened	()and	therefore	possibly	t)ampered	w
ith))CIAa
or	h)a
s	the	p)ack)aging	)and	insul
)ating
m)ateri)al	been
compromised
such	th)at	the
P
roduct

K
it	m
)ay	h)ave	subjected
to	un)accept)ably
high






	
	Di)a)C
)art)a
)Clinic)al	Testing

Agree
ment
–

Non)agen



P
)age
7

of	11


temper)atures.	)Comp)any	does
not	w)arr)ant	the	perform)anc
e	of	the

P
roduct

K
it	pe
rformed	by	1))	untr)ained	or
unqu)alified	personne
l	2))CIAa
when
used	with	equipment	o
r	re
)agents	not	specified	by
the
)Comp
)any.	THIS
)CONS
T
ITUTES	THE	S
OLE	WARRANTY	WITH
REGARDS	TO
PRODU
)CT
KITS	MADE	BY	)COMPANY	EITHER
E
XPRESSED	OR	IMPLIED.	THERE

ARE	NO	OTHER	WARRANTIE
S	EXPRESSED	OR	IMPLIED	WHI)CH	EXTEND
BEYOND	THE
FA)CE
HEREO
F
,	HEREIN,	IN)CLUDING	THE
IMPLIED	WARRANTIES	OF	MER)CHANTAB
ILITY	AND
FITN
E
SS	FOR	A	PAR
TI)CULAR	PURPOSE.	I
N	NO	EVENT	SHALL

)COMPANY	BE	LIABLE	FOR	ANY	IN)CID
ENTAL	OR
)CONSEQUENTIAL	DAM
AGES	AND	)COMPANY’S	REME
DIES	SHALL	BE	LIMITED	TO	REPAIR	OR	REPLA)CEMENT
OF	NO
N)CONF
O
RMING
KITS
..


B.

Misus
e	of	Product.

Any	t)ampering,	misuse	o
r	negligence
i
n	h)andling	o
r	use	of	Product
Ki
ts
renders	the
w)arr)anty	void.	Further,	the	w)arr)a
nty	is	void	if,	)at	)an
y	time,

)Clinic)al	L)abor)atory

)attempts	to	m)ake	)any	intern)al
ch)anges	to	)any	o
f	the

comp
onents	of	the	Product

Kit
;	if	)at	)any	time	the	power	suppli
ed	to	)any	p)ar
t

of	the
Prod
uct
Kit
exceeds	the

r)ated	toler)anc
e;	if	)any	extern)al	device	)att)ache
d	by
)Clinic)al	L)abor)at
ory

cre)at
es
conditions	exce
eding	the	toler)ance	of	the	Product

Kit
;	or	if	)a
ny	ti
me	th
e	seri)al	number	pl)ate

is	removed	or
def)aced.	USE	OF	PRODU)C
T
KIT
THAT	RE
N
DERS	THIS	WA
RRANTY	VOID	WILL	BE

DEFINED	TO	IN)C
LUDE	ALL	OF
THE	POSSIBILITIES	DES
)CRIBED	IN	THIS	PARAGR
APH,
TOGETHER	WITH	ANY	PRA)C
TI)CE	WHI)CH	RESULTS	IN
)CONDITIONS	EX)CEEDING	THE
DESIG
N	TOL
ERAN)CE	OF	THE	PRODU)CT
..


PART
9
..
TERM	AND	TERMINATION


A.

Ter
m.

The	term	o
f

this	Agreem
ent	sh)all	commence
on	the	Effectiv
e	D)ate	)and	continue	for	)a	period
of	three
(3))	ye)ars	(t
he	“Term”))Cha,	except	th)at	if
)any	Work	Order	is	still	in	progress	upon	the	ex
pir)at
ion	o
f	such	three	(3))
ye)ar

period,	the	Term	will	expire	upon	co
mpl
etion	of	t
h
e	rel)ated	Wo
rk	Order.		Upon	exp
ir)ation,	the	p)a
rties
m)ay	mutu)ally	)agree	to	renew

the	Term	for	)any	per
iod	specified	in	)a	written
)amendment	to	this	Agreement.
Otherwise,	neithe
r	p)ar
ty	sh
)all	h)ave	)any	rem)ainin
g	oblig)ation	)arising	under	this	Agree
men
t.

Termin)a
t
ion	sh)all
no
t	relieve	either	p)a
rty	of	oblig)ati
ons	incurred	prior	thereto.


B.

Term
ination.

I
n	)addition
to	the	rights	of	termin)atio
n	provided	elsewhere	in	this	Agreement,	)and	wit
hout
limit
ing	)any	other	rights
or	remedies	)av)ail)able	to	)a	p)arty,	the

Term	of	this

Agree
ment	m)a
y	be	termin)ated:


)a.

b
y	)Comp)any,	)at	)a
ny	time	within	three	hundred	)and
sixty	five	(365))Cla	d)ays

)after	the	Effective	D)ate	o
f
this	Agreement,	for	)any	re)ason,	immedi)ately	u
pon	w
ritte
n	notice	to	)Clinic)al
L)abor)atory;



b.

by	)Comp)any,	)at	)any
time	)after	th
r
ee	hundred	)a
nd	sixty	five	(365))

d)ays	)after	the

Effective	D)ate	of	this
Agreement
,	for	)any	re)ason,	upo
n	ninety	(90))Cha	d)ays	prior	wr
itten	notice	to	)Clinic)al	L)abor)atory;


d.			by	e
ither

p)art
y	bec)ause	of	)any	m)ate
ri)al	bre)ac
h	of	this	Agreement	by	the
other	p)arty	u
p
on


th
irty	(30))CIAa	d)ays	prio
r	written	notic
e;	provided,	however,	th)at	if	suc
h	bre)aching	p)arty	sh)a
ll


within	the	for
egoing	thirty	(30))Cga	d)ay	period	cure	such	bre)ach,

then

such

notice	of	termin)atio
n


sh)all	be	of	no	effect;	or


)a.

b
y	either	p)art
y

immedi)ately

upon	written	notic
e	in	the	event
th)at	the	other	p)arty	ce)ases	to
fu
nction
)as	)a	going	con
cern;	the	other	p)arty	ce)ase
s	to	conduct	its	oper)ation	in	the	norm)al
course

of	b
usine
ss;
)a	receiver	is	)app
ointed	for	the	other	p)arty;	)a	court	o
rders	the	sei
z
ure	or
suspe
nsion	of	the	other
p)arty’s	rights
or	properties;	or	the	other	p)arty

otherwise	t)akes

)adv)a
nt)age	of	)any	b)ankruptcy	or
insolvency	l)aw.








	
	Di)a)C
)art)a
)Clinic)al	Testing

Agree
ment
–

Non)agen



P
)age
8

of	11


C.

Effect	of	Termination
..	The
def
initi
ons	)a
nd
provisions	of
P
)art

7
,
8,	9B	)and	10

survive	expir)ation	o
r
termin)ation

of	this	Agre
ement	for	)any	re)aso
n.		Upon	expir)a
tion	or	termin)ation	of	this	Agree
ment,
)Clinic)al
L)abor)a
tory
’s	rights	)and	license	u
nder
P)art

1

sh)all	termin)ate.	In	)addition,	e)ach
p)arty

sh)al
l	ce)ase	use	of	the
ot
her
p)arty’s	)Confidenti)al	Inform)ation,

)and	e)ach	p)ar
t
y	sh)all	retu
rn	to	the	other	p)ar
ty	)all	of	such
other	p)arty’s
)Confidenti)al	Inform
)ation	(including	)all
copies,	notes,	summ)aries	or

other	document)ation	incorpor)ating
)Confidenti)al

Info
rm)ati
on))Cha,	m)ateri)als	)and	pr
oper
ty;	provided,	however,	th)at	e)ach
p)arty	m)ay	ret
)a
in	one	copy
of	)any	such	inform)a
tion	)and	m)ateri
)als	in	such	p)arty’s	L)aw	Dep)artmen
t	for	)archive	purpose
s,	)and	e)ach	p)arty
sh)all	not

be	required	to	destroy	or	delete	copies	th)at	h
)ave	b
ecome

embedded	in	its	elec
tron
ic	stor)age
systems	through	routin
e	b)ackup	proc
e
sses,	)and	fu
rther	provided	th)at

)Comp)any

m)ay	co
ntinue	ret)aining
)and/or	using	inf
orm)ation	included	in
reports	furnished	by
)Clinic
)al	L)abor)atory

pursu)ant	to
P)art

1	)and	2

)above,	s
olely

in	o
rder	to	verify
)Clinic
)al	L)abor)atory
’s	fulfilment	of	its	p)ay
ment	oblig)ati
o
ns	under	thi
s
Agreement.
Any	te
rmin)ation
of

)Cl
inic)al	L)abor)atory

by
)Comp)any
,

sh)a
ll	not	relieve
)Clinic
)al	L)abor)atory

of	)any
oblig)a
tion	or	li)ability	)accrued	under	this	Agreement
prior

to	s
uch	te
rmin)ation	or	re
scind	)any	p)ayment
..
Termin)ation	sh)all
not	)affect	in

)any	m)anner	)a
ny	rights	or	oblig)a
tion	of
)Comp)any

)arising	under	this	Agreement
pri
or	to	such	termin)atio
n.





P
ART
1
0
..	GENERAL	PROVISIONS


A.

Relationship	of	Parties.
The	rel)ati
onship	betwee
n

the	p)arties

est)ablished	by	thi
s	Agreement	sh)a
ll	be	solely
th)at	of	vendor	)and	v
endee	)and	)all	rights
)and	powers	not	expressly	gr
)anted	to	the
)Clinic)al	L)abor)atory
)are
expressly
reser
ved	t
o	the	)C
omp)any.	The
)Cl
inic)al	L)abor)atory
sh)all	h)ave	no	right
,	power	or	)au
t
hority	in	)an
y
w)ay	to	bind	the	)C
omp)any	to	the	f
ulfillment	of	)any	condition	not	h
erein	cont)ained,	or	t
o	)any	contr)act	or
oblig)atio
n,	expressed	or	implied.


B.

Independent	Parties.

Nothi
ng	co
nt)ained	in	this	Agree
ment	sh)all	be	construed	to	m)ake	the

)C
linic)al
L)abor
)a
tory
the	)age
nt	for	the	)Comp)any
for	)any	purpose
,	)and	neither	p)arty	hereto	sh)all
h)ave	)any	right
wh)atso
ever	to	incur	)any	li)abiliti
es	or	obli
g)ations	on	beh)alf	or	binding	upon	the

othe
r	p)ar
ty.	The
)Clinic)al
L)abo
r)atory

specific)ally	)agrees	th)at	it	sh
)all	h)ave	no	p
o
wer	or	)autho
rity	to	represent	t
he	)Comp)any

in	)any
m)anner;	th)at	it	will	solicit	o
rders	for	products	)as

)an	independent	contr)a
ctor
in	)accord)ance	with	the	terms	of
this	Agreement
;

)and	th)at
it	will	not	)at	)any	ti
me	represent	the	)Comp)any	in	)any	m)anne
r;	th)at	it	wi
l
l	solicit
or
ders	for	products	)a
s	)an	indep
endent	contr)actor	in	)accord)ance	with	t
he	terms	of	this	Agre
ement;	)and	th)at
it	wil
l	not

)at	)any	time	represent	or)ally	or	in	writing	to

)any	person

or	corpor)ation	or	ot
her	business	entity	th)at
it	h)as	)any	r
ight,	power	o
r

)authority	n
ot	expressly	gr)ante
d	by	this
Agreement.


C.

Indemnity.

)Clinic)al	L)abor
)atory	sh)all	indemnify
,	defend	)and	hold	h)armless
)Comp)any	)and	its	officers,
employees	)and	sh)areh
o
lders	(her
ein	referred	to	joint
ly	)and	sever)ally	)as	“
)Comp)any	Indemnit
ees
”))Cla	from	)an
d

)ag)ainst	)any

third	p)arty	cl)aim,

)and	)all	r
esulting	)and/or	rel)a
ted	li)ability,	d)am
)age,	loss,	costs	)and
expenses
including	re)ason)ab
le	out	of
-
pocket	leg)al	costs,	re)ason)able	out	o
f
-
pocket	)at
torneys’	fees	)and	lit
ig)ation
expenses	incurred	by	or	impos
ed	upon	the	)C
o
mp)any	Indemn
itees	)as	)a	result	o
f	)and/or	)a
rising	from:	(i))	the

development,	m)ark
eting,	s)ale,	perform)a
nce,	use	or	other	commerci)a
liz)ation	)and/or	exploit)ation	of	)any
Service	by

)Clinic)al	L
)abor)atory	or	)any	pers
on	)acting	in	the	n)ame	of	or	on	beh)alf

of	)any	of	th
e

foregoing,
or
)acquiring,	direc
tly	or	ind
irectly,	)any	Service

from	)any	of	the	f
oregoing;	(ii))Cha	the	ex
ploit)ation	or	use	of	produc
t
kit	by	)Clinic)al	L)abor)atory;	(iii))Cla	)and/or	bre
)a
ch	of	this

Agreement	by	)Clinic)a
l	L)abor)atory’s.		Notwithst)anding	the
foregoing,	th
e

foregoing	o
blig)ation	of	)Clinic
)al	L)abor)at
ory	sh)all	not	)apply
to	the	extent	th)at

)any	cl)aim	rel)ates
to

or	)arises	from	)any	misrepr
esent)ation,	negligence	or	willful	misconduct	o
f

)Comp)any,
or	from	)Comp)any’s
bre
)ach	of	this	Agreement.









	
	Di)a)C
)art)a
)Clinic)al	Testing

Agree
ment
–

Non)agen



P
)age
9

of	11


D.

Assign
ment.

Neither

this	Agreeme
nt	nor	the	respecti
ve	rights
)and	oblig)ations	of	the	p)arties	under	t
his
Agreement	m)ay	be
)assigned,	tr)ansferred,	dele
g)ated	or
subcontr)acted	in	whole	or	in	p)art,	by

either	p)ar
ty	to
)any	other	Entit
y	without	the	prior	written	consent	o
f	the	other	p
)a
rty	which	co
nsent	sh)all	not	be
unre)ason)ab
ly	denied,	conditioned	or	del)ayed.	Not
withst)anding	the	fore
going,	)Comp)any	sh)all	be	ent
itled	to
)assign	this	Agreement	(in	whole	or	in

p)art))Cha	or	i
ts	rights	)and	oblig)at
ions	hereunder	to	)an	Affili)ate	or	to
)a	third
p)arty

th)at	succeed
s	to	)all	or	subst)an
ti)ally	)all

of	the	business	or	)assets	of	)Comp)any
rel)ating	to	this	Agre
ement
whether	by	s)ale,	merg
er,	oper)a
tion	of	l)aw	or	otherwise,	provided	in

e)ach	c)ase
th)at	such	)assignee	)ag
rees	to
be	bound	in	writing	by	the	te
rms	of	this	A
g
reement.	Sub
ject	to	the	prior	s
entence,	t
he	rights,	duties,	)and
oblig)ations	of
the	p)arties	under	thi
s	Agreement	sh)all	inure	to
the	benef
it	)and	sh)all	be	binding	upon	their
re
s
pective	su
ccessors	)and	permitte
d	)assigns.


E.

Insurance
..

)Clinic)al	L)ab
or)atory	sh)all

procure	)and
m)aint)ain,	)at	its	so
le	cost	)an
d	expense,	insur)ance	policies	in
)amoun
ts	re)ason)able	)and	cus
tom)ary	in	the	industry	)and
sufficient	to	cover	its	li)abilities	)and	oblig)a
t
ions	under

this	Agreement,	t)aki
ng	into	)account	the	)actu
)al	st)age	of	S
ervice	develo
p
ment	)and	com
merci)aliz)ation	of	)a
ny
product

kit.

The	insur)ance	cover)age	required
)above	sh)all	not	be	co
nstrued	to	cre)ate	)a	limit	o
f	)Clinic)al
L)abor)atory’s	li)ability	with	respect

to	its	ind
emnific)ation	oblig)ati
ons	under	the	)above	Sec
tion.

)Clinic)al

L)abor)atory	s
h
)all	provide
)Comp)any	with	writte
n	evidence

of	such	insur)ance	upon	request.


F.

Own
ership
..

For	purposes
of	cl)arific)ation,	the	p)arti
es	)acknowledge	)and	)agree	th)at	this	Agreement	i
s

not
inten
ded	to	nor	)assigns	or

wi
ll	)assign,	or	tr)ansfer	)any	ownersh
ip	of	intelle
c
tu)al	propert
y	or	know
-
how	owned

by	)Comp)an
y	to	)Clinic)al	L)abor)atory.		Inventorshi
p	of	)any	invention	in
vented	or	cre)ated	in	connec
tion	with
this	Agreement	will	be	determined	by

United	St)a
tes	p)atent	l)aw,	)and	o
wne
rship	sh)all	follow	inventorship.


G.

Status	of	P
a
rties
..

This
Agreement	cre)ates	n
o	rel)ation
ship	of	joint	venturers,	p)artners,	or
princip)al	)and	)agent
b
etween	the	p)arties.		Furthe
r,	neither	p)arty	sh)all	be	)authorized	to	)act	on

beh)alf	of,

or	ot
herwise	bind	th
e
other	p)arty.


H.

Notices
..

Any	notice	c
ontempl)ated	o
r

required	or

permitted	to	be	gi
ven	under
this	Agreement	(including
without	limi
t)ation	invoices	)and	b
illing	inform)ation))CIAa	sh)all	b
e	sufficient	if	in	writing	)and	prep)aid	)and	if
(
i))CIAa
deliver
ed	person)ally,	(ii))Cga	s
ent	by	registered	or	cer
tified	m)ail,
return	receip
t

requested,
or	(iii))Cha	sent	by	ex
press
deli
very	service	(such	)as	Feder)al	Express))

where	the	recipient
must	execute	its	receipt,	t
o	the	p)arties’
respective	)addresses	below,	or
t
o	such	oth
er	)addresses	)as	eithe
r	p)arty	hereto	m)ay	here)a
fter	design)at
e	in
writing.








Non)ag
en
:


Non)agen	Biosci
ence	)Corp.

Attn:

Business

Development

3680	Wilsh
ire	Blvd,	Ste	P04
-

1
399

Los	Angeles,	)CA	90010



Di)a)C)art)a
:


Aiguo	Zh)ang,	Ph.D.

Di)a)C)art)a	Inc.


4385	Hopy)a
rd	Rd,	Ste	100

Ple)as)a
nton,	)CA	94588

United	St)ates	of	Ameri
c)a


With	co
p
y

for	Notice

purposes,	to
:






with	)a	copy	sent	to
:











	
	Di)a)C
)art)a
)Clinic)al	Testing

Agree
ment
–

Non)agen



P
)age
10

of	11


I.

E
ntire	Agr
e
ement.

The

entire	Agreement	between	the	)Comp)any	)and	the
)Clinic)al	L)abor)a
t
ory

covering

the
Product

Kit

is	set	forth	herein	)and

)any	)amendment	or	modific)ation	sh)all
b
e	in	writing	)and	sh)all	be	executed
by

duly	)au
thorized	represent)ativ
es	in	the	s)ame	m)a
nner	)as	t
h
is	Agreeme
nt.	The
provisions	of	this	Agreement
)are	sever)able,	)and	if	)an
y

one	or	more

such	provisions	)are	determined	to	be	il
leg)al	or	otherwise
unenforce)able,	in
w
hole	or	in	p)art,	under	the	l)aws	of	)an
y	jurisd
iction,	the	rem)aining
provisions	or	por
tions
her
e
of	sh)all,
neverthe
less,	be	binding	on	)and	enforce)able	by	)and	between	th
e

p)arties	her
eto.	Any
provisions,	terms	or	conditions

of
)Clinic)al	L)abor)atory

's	Purch)ase	O
r
ders	which	)are,	in	)any	w)ay	contr)adict
ing
of	t
his	Agreeme
nt,	except	those	)addition)al
provision
s

specifyin
g	qu)antity	)and	sh
ipping	instructions,	sh)all	not
be	binding	up
o
n	)Comp)any	)an
d	sh)all	h)ave	no	)applic)ability	to	the	s)ale	of	good
s	by	)Comp)any	to
)Clinic)al
L)ab
o
r)atory
..


J.

Publicity.

E)ach	p)arty	is	fr
ee	to	m)a
ke	public	the	existence	of	this	Agreeme
nt	once	s
i
gned	by	bo
th	P)arties.	The
P)arties	)a
gree	to	m)ake	every	best	effort	to	jo
i
ntly	publici
ze	this	Agreement.


K.

Applicable	Law.

This	Agreement	sets
out	the	entire	)agree
m
ent	)and	underst)anding	between	)Comp)any

)and
)Cli
nic)al	L)abor)atory

)and	sh)all	be	governed
by	)and	co
n
strued	in
)accord)ance	with	the	l)aws	of	the	S
t)ate	of
New
York
;	)and	)Comp)an
y

)and
)Clinic)a
l	L)abor)atory

hereby	irrevoc)ably	submit	to	the	exclusive	jurisdiction	of	t
he
c
o
urts	of	the	St)ate	of
Ne
w
York
..


L.

Sepa
rate	Pro
visions.

If	)any	provision	of	this	Agree
ment	sh)al
l

be	held	t
o	be	i
nv)alid,	illeg)al	or	unenforce)able,
the	v)alidity,	leg)alit
y

)and	enforce
)ability	of	the	rem)aining	provisions	sh)all	in	no	w)ay	be	)affected	or	imp)air
ed
t
h
ereby.


M.

Miscellaneous
..

This	Agreemen
t	m)ay	be

executed	in	counterp)arts	in	order	to	p
rovide	e)a
c
h	p)arty	wi
th	)a	fully
-
executed	origin)al	hereof.		This	Agreement	m)ay	not
b
e	ch)anged,	m
odified	or	)amended	except	by	)an
)agreement	in	writing	signed	by	both	p)arti
es.

The	provisions	of	this
Agreement	)are
hereby	d
eemed	by	the
p)arties	to	be	sever)able,	)a
nd	the	in
v
)alidity	or

unenforce)ability	of	)any	one	or	more	of	the	provisions	of	thi
s

Agreement	s
h)all	not	)affect	the	v)alidity	)and	enforce)ability	of	the	rem)aining	provisio
ns	t
h
ereof.		The	w)aiver	by
)a
ny	p)arty	to	th
is	Agree
ment	of	)any	bre)ach	or	viol)ation	of	)any
provision
s

of	this	A
greement	by	)any	other
p)arty	hereto	sh)all	not	oper)ate	)as	)a	w)ai
v
er	of	)any	ot
her	bre)ach.		Titles	)and	he)adings	of	sections	of	this
Agreement	)are	for	co
nven
i
ence	)and	reference	only

)and	sh)all	not

)affect
the	construction	of	)any	provisions	of
t
his	Agree
m
ent.		This

Agreement	reflects	the	complete	underst)anding	of	the	p)arties

)and	constitu
tes	their
entire	)agreement	reg)arding	its	subject	m)atter,	superseding	)all
prio
r

verb)al	or	written	nego
ti)ations,
repr
esent)ati
ons,	)agreements,	underst)andings,	)and	st
)atements
r
eg)arding	t
he	subject	m)atter	herein.


IN	WITNESS	WHEREOF,	the	p)arties	h)a
v
e	c)aused	thi
s	Agreement	to	be	executed	by	their	duly	)authorized	officers
)as	of	the	d)a
te	)a
n
d	ye)ar	indic)ated	)ab
ove.




COMPANY






CLIN
ICAL	LABORATORY


By:	_________________________________


By:



)Ch)arles
Rosser






Aiguo	Zh)ang,	Ph.D

)CE
O







)CEO

Non)agen	B
ioscience	)Corpor)ation



Di)a)C)art)a,	Inc